TNDM 241220 33.00P (TNDM241220P33000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

TNDM241220P33000

Watchlist

2.95
0.000.00%

15min DelayTrading Nov 21 11:27 ET

0.00High0.00Low

Intraday

5D
Daily

News

Citi Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Cuts Target Price to $50
Moomoo News07:31 ET · Ratings
Express News | Tandem T:Slim X2 Insulin Pump Now Compatible With Dexcom G7 Cgm in Canada
ReutersDec 10 09:00 ET
Express News | Tandem Diabetes Care Inc : Canaccord Genuity Raises Target Price to $63 From $56
ReutersDec 9 03:37 ET
TD Cowen Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Cuts Target Price to $40
Moomoo NewsDec 6 12:31 ET · Ratings
Tandem Diabetes Care Poised for Growth: Expansion Into Type 2 Diabetes and Strategic Integration Drive Buy Rating
TipRanksDec 6 12:15 ET · Ratings
Tandem Diabetes Care (TNDM) Down 9.2% Since Last Earnings Report: Can It Rebound?
Yahoo FinanceDec 6 11:31 ET

Comments

mad541

Aug 2 11:48

company needs money this always drops 35% after earnings I'm out

mad541

Aug 2 11:46

$Tandem Diabetes Care (TNDM.US)$ company needs money this always drops 35% after earnings I'm out 🩸🩸🩸

Trytosaveabit

Aug 1 15:13

Update

$Tandem Diabetes Care (TNDM.US)$ Second Quarter 2024 Highlights
-- Worldwide GAAP sales increased 13 percent to $221.9 million compared to
second quarter 2023; worldwide non-GAAP sales(1) increased 12 percent to
$221.8 million compared to second quarter 2023.
-- More than 20,000 pumps shipped in the United States, a sequential
increase of 33 percent compared to first quarter 2024.
-- Launched Tandem Mobi with Dexcom G7 continuous glucose monitoring (CGM)
sensor integration in th...

70862468

May 21 11:11

Stock moves

$Tandem Diabetes Care (TNDM.US)$
Just check call options. they are expensive
However, stock price moves only 5-10% with no news. Something is going on behind the scene?!

Moomoo AI

Mar 22 05:56

Despite losses and negative cash flow, the company's US$178.2m balance sheet allows for at least two years of growth spending. However, the stock is seen as risky due to these financial conditions.

Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?